Visceral leishmaniasis (kala azar)

During the active phase, medical records and laboratory results that document a current diagnosis of visceral leishmaniasis support the 100 percent rating. After treatment ends, the six-month mandatory VA examination is the key event. Records showing the date treatment stopped help establish when that exam should occur. If residual conditions develop — for example, liver damage or bone marrow disease — medical records, imaging, biopsy results, blood work, and specialist notes that document those specific conditions become the relevant evidence, because VA will rate them under the appropriate body system. If the disease appears to recur, culture results, histopathology reports, or other laboratory testing confirming active infection are required. Statements from you or treating providers describing how ongoing symptoms affect your daily life and work can support the rating of any residual disability under whichever body system applies.